EBS — Emergent BioSolutions Inc. stock price, charts and financials

QT43Emergent BioSolutions Inc.

Emergent BioSolutions Inc. (NYSE: EBS) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
6.80
-0.22-3.13%
OverviewShort InterestFilings
EBSQT43Emergent BioSolutions Inc.·NYSE
6.80-3.13%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 14, 20268-KCurrent report
Sep 01, 20268-KCurrent report
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 12, 20263Initial statement of beneficial ownership
Aug 06, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 31, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 01, 20264Statement of changes in beneficial ownership
May 01, 20264Statement of changes in beneficial ownership
#1 / 25 of 433
Page
▼
/ 18